| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Immunome Inc. | CHIEF LEGAL OFFICER & GC | Stock option (right to buy) | 210,000 | 09 Aug 2024 | Direct | ||
| Immunome Inc. | CHIEF LEGAL OFFICER & GC | Employee Stock Option (right to buy) | 190,000 | 29 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMNM | Immunome Inc. | 29 Jul 2025 | 1 | $0 | 4 | CHIEF LEGAL OFFICER & GC | 31 Jul 2025, 18:48 |
| IMNM | Immunome Inc. | 09 Aug 2024 | 1 | $0 | 4 | CHIEF LEGAL OFFICER & GC | 13 Aug 2024, 17:54 |
| IMNM | Immunome Inc. | 31 Jan 2024 | 1 | $0 | 4 | CHIEF LEGAL OFFICER & GC | 31 Jan 2024, 20:50 |
| IMNM | Immunome Inc. | 08 Jun 2023 | 1 | $0 | 4 | General Counsel and CLO | 12 Jun 2023, 17:01 |
| IMNM | Immunome Inc. | 16 Jun 2022 | 1 | $0 | 4 | General Counsel and CLO | 21 Jun 2022, 18:07 |
| IMNM | Immunome Inc. | 28 May 2021 | 1 | $0 | 4 | General Counsel and CLO | 01 Jun 2021, 19:19 |